These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28559259)

  • 1. Simkania negevensis, an Example of the Diversity of the Antimicrobial Susceptibility Pattern among Chlamydiales.
    Vouga M; Baud D; Greub G
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simkania negevensis strain ZT: growth, antigenic and genome characteristics.
    Kahane S; Everett KD; Kimmel N; Friedman MG
    Int J Syst Bacteriol; 1999 Apr; 49 Pt 2():815-20. PubMed ID: 10319507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simkania negevensis may produce long-lasting infections in human pneumocytes and endometrial cells.
    Vouga M; Baud D; Greub G
    Pathog Dis; 2017 Jan; 75(1):. PubMed ID: 28087650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simkania negevensis, an insight into the biology and clinical importance of a novel member of the Chlamydiales order.
    Vouga M; Baud D; Greub G
    Crit Rev Microbiol; 2017 Feb; 43(1):62-80. PubMed ID: 27786615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth cycle of Simkania negevensis.
    Kahane S; Kimmel N; Friedman MG
    Microbiology (Reading); 2002 Mar; 148(Pt 3):735-742. PubMed ID: 11882708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibility of Estrella lausannensis, a potential emerging pathogen.
    de Barsy M; Bottinelli L; Greub G
    Microbes Infect; 2014 Sep; 16(9):746-54. PubMed ID: 25150688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms.
    Everett KD; Bush RM; Andersen AA
    Int J Syst Bacteriol; 1999 Apr; 49 Pt 2():415-40. PubMed ID: 10319462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility of Neochlamydia hartmanellae and Parachlamydia acanthamoebae in amoebae.
    Vouga M; Diabi H; Boulos A; Baud D; Raoult D; Greub G
    Microbes Infect; 2015; 17(11-12):761-5. PubMed ID: 26279002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of a "new" bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patients.
    Angeletti A; Biondi R; Battaglino G; Cremonini E; Comai G; Capelli I; Donati G; Cevenini R; Donati M; La Manna G
    BMC Nephrol; 2017 Apr; 18(1):133. PubMed ID: 28407799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors improving the propagation of Simkania negevensis strain Z in cell culture.
    Yamaguchi T; Yamazaki T; Inoue M; Ogawa M; Shiga S; Nakagawa Y; Kishimoto T; Ouchi K; Ohzeki T
    Jpn J Infect Dis; 2004 Jun; 57(3):103-6. PubMed ID: 15218218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.
    Goy G; Greub G
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2663-6. PubMed ID: 19332673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections with the chlamydia-like microorganism Simkania negevensis, a possible emerging pathogen.
    Friedman MG; Dvoskin B; Kahane S
    Microbes Infect; 2003 Sep; 5(11):1013-21. PubMed ID: 12941393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the presence of Simkania negevensis in drinking water and in reclaimed wastewater in Israel.
    Kahane S; Platzner N; Dvoskin B; Itzhaki A; Friedman MG
    Appl Environ Microbiol; 2004 Jun; 70(6):3346-51. PubMed ID: 15184130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of Acanthamoeba polyphaga with Simkania negevensis and S. negevensis survival within amoebal cysts.
    Kahane S; Dvoskin B; Mathias M; Friedman MG
    Appl Environ Microbiol; 2001 Oct; 67(10):4789-95. PubMed ID: 11571186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versatility of Simkania negevensis infection in vitro and induction of host cell inflammatory cytokine response.
    Kahane S; Fruchter D; Dvoskin B; Friedman MG
    J Infect; 2007 Aug; 55(2):e13-21. PubMed ID: 17466379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simkania negevensis in Crohn's Disease.
    Scaioli E; Biondi R; Liverani E; Sartini A; Troiano A; Fuccio L; Muratori R; Lombardi G; Onorini D; Dal Monte P; Donati M; Belluzzi A
    Dig Dis Sci; 2019 Nov; 64(11):3284-3290. PubMed ID: 31041636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the true clinical relevance of
    Vouga M; Kebbi-Beghdadi C; Liénard J; Baskin L; Baud D; Greub G
    New Microbes New Infect; 2018 May; 23():1-5. PubMed ID: 29692903
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of Host Cell Death and Lysis Are Required for the Release of
    Koch RD; Hörner EM; Münch N; Maier E; Kozjak-Pavlovic V
    Front Cell Infect Microbiol; 2020; 10():594932. PubMed ID: 33194844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.